Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
4.7M
-
Shares change
-
+199K
-
Total reported value, excl. options
-
$107M
-
Value change
-
+$4.64M
-
Number of buys
-
25
-
Number of sells
-
-26
-
Price
-
$22.80
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2020
62 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q4 2020.
IRADIMED CORP - Common Stock (IRMD) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.7M shares
of 12.7M outstanding shares and own 36.91% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (738K shares), Nine Ten Capital Management LLC (664K shares), Russell Investments Group, Ltd. (421K shares), BlackRock Inc. (407K shares), VANGUARD GROUP INC (377K shares), Soleus Capital Management, L.P. (304K shares), RK Capital Management, LLC (238K shares), RICE HALL JAMES & ASSOCIATES, LLC (229K shares), Ranger Investment Management, L.P. (220K shares), and Mondrian Investment Partners LTD (178K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.